Literature DB >> 1419309

Interleukin-2 therapy for metastatic uveal melanoma.

T Dorval, W H Fridman, C Mathiot, P Pouillart.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1419309     DOI： 10.1016/0959-8049(92)90266-5

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  8 in total

1.  Identification of an Immunogenic Subset of Metastatic Uveal Melanoma.

Authors:  Luke D Rothermel; Arvind C Sabesan; Daniel J Stephens; Smita S Chandran; Biman C Paria; Abhishek K Srivastava; Robert Somerville; John R Wunderlich; Chyi-Chia R Lee; Liqiang Xi; Trinh H Pham; Mark Raffeld; Parthav Jailwala; Manjula Kasoji; Udai S Kammula
Journal:  Clin Cancer Res       Date:  2015-12-28       Impact factor: 12.531

Review 2.  Latest developments in the biology and management of uveal melanoma.

Authors:  Sapna P Patel
Journal:  Curr Oncol Rep       Date:  2013-12       Impact factor: 5.075

Review 3.  Immunotherapy for uveal melanoma.

Authors:  Dae Won Kim; Jaime Anderson; Sapna P Patel
Journal:  Melanoma Manag       Date:  2016-05-19

4.  Treatment of metastatic uveal melanoma with adoptive transfer of tumour-infiltrating lymphocytes: a single-centre, two-stage, single-arm, phase 2 study.

Authors:  Smita S Chandran; Robert P T Somerville; James C Yang; Richard M Sherry; Christopher A Klebanoff; Stephanie L Goff; John R Wunderlich; David N Danforth; Daniel Zlott; Biman C Paria; Arvind C Sabesan; Abhishek K Srivastava; Liqiang Xi; Trinh H Pham; Mark Raffeld; Donald E White; Mary Ann Toomey; Steven A Rosenberg; Udai S Kammula
Journal:  Lancet Oncol       Date:  2017-04-07       Impact factor: 41.316

5.  Treatment of disseminated ocular melanoma with sequential fotemustine, interferon alpha, and interleukin 2.

Authors:  J C Becker; P Terheyden; E Kämpgen; S Wagner; C Neumann; D Schadendorf; A Steinmann; G Wittenberg; W Lieb; E-B Bröcker
Journal:  Br J Cancer       Date:  2002-10-07       Impact factor: 7.640

Review 6.  Systemic treatment of metastatic uveal melanoma: review of literature and future perspectives.

Authors:  Kristina Buder; Anja Gesierich; Götz Gelbrich; Matthias Goebeler
Journal:  Cancer Med       Date:  2013-09-18       Impact factor: 4.452

7.  Development and external validation of a prognostic nomogram for metastatic uveal melanoma.

Authors:  Sara Valpione; Justin C Moser; Raffaele Parrozzani; Marco Bazzi; Aaron S Mansfield; Simone Mocellin; Jacopo Pigozzo; Edoardo Midena; Svetomir N Markovic; Camillo Aliberti; Luca G Campana; Vanna Chiarion-Sileni
Journal:  PLoS One       Date:  2015-03-17       Impact factor: 3.240

8.  Parallel profiling of immune infiltrate subsets in uveal melanoma versus cutaneous melanoma unveils similarities and differences: A pilot study.

Authors:  Yong Qin; Mariana Petaccia de Macedo; Alexandre Reuben; Marie-Andrée Forget; Cara Haymaker; Chantale Bernatchez; Christine N Spencer; Vancheswaran Gopalakrishnan; Sujan Reddy; Zachary A Cooper; Orenthial J Fulbright; Renjith Ramachandran; Arely Wahl; Esteban Flores; Shawne T Thorsen; Rene J Tavera; Claudius Conrad; Michelle D Williams; Michael T Tetzlaff; Wei-Lien Wang; Dan S Gombos; Bita Esmaeli; Rodabe N Amaria; Patrick Hwu; Jennifer A Wargo; Alexander J Lazar; Sapna P Patel
Journal:  Oncoimmunology       Date:  2017-05-08       Impact factor: 8.110
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.